Articles

Podcasts

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Italy and the Netherlands both achieved their target HBV control. 

Hepatitis B Dosing Programs A Challenge in Europe

Genotype F was the common genotype found at 5.73 per 1000 person-years of follow-up.

Hepatitis B Virus Genotypes Identified in Alaska

Patients with IBD, rheumatoid arthritis, and psoriasis are commonly treated using biologic agents such as infliximab, tofacitinib, and ustekinumab.

Hepatitis B Reactivation Rare in Biologic Exposed Patients

A recent study has found statins are underutilized for NASH and NAFLD patients. 

Mary Thomson, MD: The Future of NASH Care

The rare liver disease can often lead to liver failure. 

FDA Approves Odevixibat for PFIC

The issuance comes within a week of the planned PDUFA date for the drug's possible indication as an adult CKD therapy.

FDA Issues Letter to Ardelyx for Submission of Tenapanor for Chronic Kidney Disease

The researchers found sero-protection rate at 12-month was significantly higher in the ID arm compared to the IM cohort.


ID Hepatitis B Vaccination with Topical Imiquimod Safe for IBD Patients 

Biologic use was not associated with an increased risk of hepatitis B virus flares.

IBD Patients Exposed to Steroids at an Increased Risk of Hepatitis B Flares

More than 56% of these patients enrolled in TARGET-NASH were being treated with statins.

Mary Thomson, MD: Increasing Statin Use for NAFLD Patients

A maternal-infant HCV linkage program in combination with a multidisciplinary clinic to collocate mother and infant care was implemented in 2016.

Linkage to Care Leads to More Hepatitis C Treatment for Pregnant Women

Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.